Anti-infective Drugs Advisory Committee
When
Dec 3, 2008 (Wednesday)
Where
What
Event Name: Anti-infective Drugs Advisory Committee Event Date(s): Wednesday, December 03, 2008 to Wednesday, December 03, 2008 Event Location: Food and Drug Administration CDER ...
Improve this event listing
Start the conversation
Event details: Anti-infective Drugs Advisory Committee
Description
Event Name: Anti-infective Drugs Advisory Committee
Event Date(s): Wednesday, December 03, 2008 to Wednesday, December 03, 2008
Event Location: Food and Drug Administration
CDER Advisory Committee, Rockville, Maryland, U.S.A.
Description: The committee will discuss new drug application (NDA) 22-268, artemether 20 mg/lumefantrine 120mg, sponsored by Novartis Pharmaceuticals Corporation, for the proposed indication of treatment of acute, uncomplicated malaria infection due to Plasmodium falciparum or mixed infections including P. falciparum.
Sponsor: FDA
Host Company: FDA
Contact Information: Phone: 301-827-7001
Fax: 301-827-6776
Email: janie.kim@fda.hhs.gov
Event Date(s): Wednesday, December 03, 2008 to Wednesday, December 03, 2008
Event Location: Food and Drug Administration
CDER Advisory Committee, Rockville, Maryland, U.S.A.
Description: The committee will discuss new drug application (NDA) 22-268, artemether 20 mg/lumefantrine 120mg, sponsored by Novartis Pharmaceuticals Corporation, for the proposed indication of treatment of acute, uncomplicated malaria infection due to Plasmodium falciparum or mixed infections including P. falciparum.
Sponsor: FDA
Host Company: FDA
Contact Information: Phone: 301-827-7001
Fax: 301-827-6776
Email: janie.kim@fda.hhs.gov
Cost
n/aPost a Countdown Widget
Countdown to this event with your own widget! You can customize it and post one on your website, MySpace page or blog.
On the MySpace bulletin board page click "Post Bulletin".
Paste code into the Body section and add a Subject to your bulletin.
Then click "Post" and you will be brought to the confirmation page.
Click "Post Bulletin" on the confirmation page and you're done!
Leave a comment after signing in or joining.